Trimodal Cancer Therapy

Cancers are treated with three types of agents: a chemotherapeutic agent which induces lymphopenia; an inhibitory antibody to a surface marker on Treg cells; and an anti-cancer vaccine. This combination may lead to enhanced immune responses despite lymphodepletion.

Patents:
US 20,110,135,637

Inventor(s): SAMPSON JOHN H [US]; MITCHELL DUANE A [US]; FECCI PETER E [US]

Type of Offer: Licensing



« More Biotech Patents

---